Related references
Note: Only part of the references are listed.RET/PTC Gene Rearrangements in Thyroid Carcinogenesis: Assessment and Clinico-Pathological Correlations
Mosin S. Khan et al.
PATHOLOGY & ONCOLOGY RESEARCH (2020)
LncRNA GAS8-AS inhibits colorectal cancer (CRC) cell proliferation by downregulating lncRNA AFAP1-AS1
Yingying Zhao et al.
GENE (2019)
LncRNA GAS8-AS1 suppresses papillary thyroid carcinoma cell growth through the miR-135b-5p/CCND2 axis
NingHeng Chen et al.
BIOSCIENCE REPORTS (2019)
BRAF-Oncogene-Induced Senescence and the Role of Thyroid-Stimulating Hormone Signaling in the Progression of Papillary Thyroid Carcinoma
F. I. Moulana et al.
HORMONES & CANCER (2018)
The long noncoding RNA GAS8-AS1 suppresses hepatocarcinogenesis by epigenetically activating the tumor suppressor GAS8
Wenting Pan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
LncRNA GAS8-AS1 inhibits cell proliferation through ATG5-mediated autophagy in papillary thyroid cancer
Yuan Qin et al.
ENDOCRINE (2018)
Plasma lncRNA GAS8-AS1 as a Potential Biomarker of Papillary Thyroid Carcinoma in Chinese Patients
Dongxue Zhang et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2017)
Whole exome sequencing identifies lncRNA GAS8-AS1 and LPAR4 as novel papillary thyroid carcinoma driver alternations
Wenting Pan et al.
HUMAN MOLECULAR GENETICS (2016)
The changing incidence of thyroid cancer
Cari M. Kitahara et al.
NATURE REVIEWS ENDOCRINOLOGY (2016)
RET/PTC Rearrangements Are Associated with Elevated Postoperative TSH Levels and Multifocal Lesions in Papillary Thyroid Cancer without Concomitant Thyroid Benign Disease
Xuan Su et al.
PLOS ONE (2016)
Significant association of TP53 Arg72Pro polymorphism in susceptibility to differentiated thyroid cancer
Mosin S. Khan et al.
CANCER BIOMARKERS (2015)
Association between rs12045440 Polymorphism in the CAPZB Intron and Serum TSH Concentrations in Chinese Thyroid Tumor Patients
Shouhao Feng et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2015)
Molecular genetics and diagnosis of thyroid cancer
Yuri E. Nikiforov et al.
NATURE REVIEWS ENDOCRINOLOGY (2011)
Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage
Megan Rist Haymart et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration
K. Boelaert et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)